Laura Ashley1, Joachim Marti2, Helen Jones3, Galina Velikova3, Penny Wright3. 1. Faculty of Health and Social Sciences, Leeds Beckett University, Leeds, UK. 2. Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. 3. Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.
Abstract
OBJECTIVE: Studies have found that illness perceptions explain significant variance in health outcomes in numerous diseases. However, most of the research is cross-sectional and non-oncological. We examined, for the first time in breast, colorectal and prostate cancer patients, if cognitive and emotional illness perceptions near diagnosis predict future multidimensional health-related quality of life (HRQoL). METHODS: UK-based patients (N = 334) completed the illness perception questionnaire-revised within 6 months post-diagnosis and the quality of life in adult cancer survivors scale 15 months post-diagnosis. Sociodemographic and clinical data were obtained from medical records. Hierarchical multiple regression analyses were conducted. RESULTS: The sociodemographic and clinical factors collectively significantly predicted 8/12 HRQoL domains, although for 5/8 accounted for <10% of the variance. For all 12 HRQoL domains, illness perceptions collectively explained significant substantial additional variance (∆R(2) range: 5.6-27.9%), and a single illness perception questionnaire-revised dimension was the best individual predictor of 9/12 HRQoL domains. The consequences dimension independently predicted 7/12 HRQoL domains; patients who believed their cancer would have a more serious negative impact on their life reported poorer future HRQoL. The emotional representations and identity dimensions also predicted multiple HRQoL domains. CONCLUSIONS: Future research should focus on realising the potential of illness perceptions as a modifiable target for and mediating mechanism of interventions to improve patients' HRQoL.
OBJECTIVE: Studies have found that illness perceptions explain significant variance in health outcomes in numerous diseases. However, most of the research is cross-sectional and non-oncological. We examined, for the first time in breast, colorectal and prostate cancer patients, if cognitive and emotional illness perceptions near diagnosis predict future multidimensional health-related quality of life (HRQoL). METHODS: UK-based patients (N = 334) completed the illness perception questionnaire-revised within 6 months post-diagnosis and the quality of life in adult cancer survivors scale 15 months post-diagnosis. Sociodemographic and clinical data were obtained from medical records. Hierarchical multiple regression analyses were conducted. RESULTS: The sociodemographic and clinical factors collectively significantly predicted 8/12 HRQoL domains, although for 5/8 accounted for <10% of the variance. For all 12 HRQoL domains, illness perceptions collectively explained significant substantial additional variance (∆R(2) range: 5.6-27.9%), and a single illness perception questionnaire-revised dimension was the best individual predictor of 9/12 HRQoL domains. The consequences dimension independently predicted 7/12 HRQoL domains; patients who believed their cancer would have a more serious negative impact on their life reported poorer future HRQoL. The emotional representations and identity dimensions also predicted multiple HRQoL domains. CONCLUSIONS: Future research should focus on realising the potential of illness perceptions as a modifiable target for and mediating mechanism of interventions to improve patients' HRQoL.
Authors: Sylwia Wieder-Huszla; Joanna Owsianowska; Anita Chudecka-Głaz; Dorota Branecka-Woźniak; Anna Jurczak Journal: Int J Environ Res Public Health Date: 2022-06-13 Impact factor: 4.614
Authors: Lauren Matheson; Mary Boulton; Verna Lavender; Andrew Protheroe; Sue Brand; Marta Wanat; Eila Watson Journal: J Cancer Surviv Date: 2015-07-10 Impact factor: 4.442
Authors: Na Zhang; Richard Fielding; Inda Soong; Karen K K Chan; Conrad Lee; Alice Ng; Wing Kin Sze; Janice Tsang; Victor Lee; Wendy Wing Tak Lam Journal: PLoS One Date: 2017-03-20 Impact factor: 3.240
Authors: Belle H de Rooij; Nicole P M Ezendam; Kim A H Nicolaije; Paul Lodder; M Caroline Vos; Johanna M A Pijnenborg; Dorry Boll; Roy F P M Kruitwagen; Lonneke V van de Poll-Franse Journal: Qual Life Res Date: 2018-03-06 Impact factor: 4.147
Authors: Melissa S Y Thong; Adrian A Kaptein; Pauline A J Vissers; Gerard Vreugdenhil; Lonneke V van de Poll-Franse Journal: J Cancer Surviv Date: 2016-03-19 Impact factor: 4.442
Authors: Rieneke T Lugtenberg; Stefanie de Groot; Ad A Kaptein; Maarten J Fischer; Elma Meershoek-Klein Kranenbarg; Marjolijn Duijm-de Carpentier; Danielle Cohen; Hiltje de Graaf; Joan B Heijns; Johanneke E A Portielje; Agnes J van de Wouw; Alex L T Imholz; Lonneke W Kessels; Suzan Vrijaldenhoven; Arnold Baars; Marta Fiocco; Jacobus J M van der Hoeven; Hans Gelderblom; Valter D Longo; Hanno Pijl; Judith R Kroep Journal: Breast Cancer Res Treat Date: 2020-11-11 Impact factor: 4.872